Nexira:企業の戦略・SWOT・財務情報

◆英語タイトル:Nexira - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4117
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥45,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥68,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Nexira – Strategy, SWOT and Corporate Finance Report
Summary

Nexira – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Nexira (Nexira) is primarily involved in developing, manufacturing, and marketing of acacia gum products. The company’s product portfolio includes emulsifiers, texturizers, antioxidants and actives. Nexira provides natural ingredients for beverage and food applications such as bakery and cereals, confectionery, encapsulation, ice cream and dairy and sauces and dressings. It also offers botanical extract ingredients which find applications in cardiovascular health, joint health, anti-ageing, gut health, weight-management and anti-stress. It operates a network of production plants across France. The company markets its products through distributors located across the Europe, the Middle East, the Americas, Asia-Pacific and Africa. Nexira is headquartered in Rouen, France.

Scope

- Detailed information on Nexira required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Nexira in the form of a SWOT analysis
- An in-depth view of the business model of Nexira including a breakdown and examination of key business segments
- Intelligence on Nexira’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Nexira, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Nexira and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Nexira as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Nexira’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Nexira: Company Overview 6
Nexira: Overview and Key Facts 6
Nexira: Overview 6
Nexira: Key Facts 6
Nexira: Key Employees 7
Nexira: Major Products and Services 8
Nexira: Company History 10
Nexira: Locations and Subsidiaries 11
Nexira: Key Competitors 12
Nexira: Company Analysis 13
Nexira: Business Description 13
Nexira: SWOT Analysis 14
Nexira: SWOT Overview 14
Nexira: Strengths 14
Nexira: Weaknesses 14
Nexira: Opportunities 15
Nexira: Threats 15
Appendix 17
Contact Us 17
Methodology 17
About MarketLine 18

List of Tables
Table 1: Nexira: Key Facts
Table 2: Nexira: Key Employees
Table 3: Nexira: Locations and Subsidiaries
Table 4: Nexira: Key Competitors



★海外企業調査レポート[Nexira:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Opiant Pharmaceuticals Inc (OPNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Henkel AG & Co. KGaA:企業のM&A・事業提携・投資動向
    Henkel AG & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Henkel AG & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Westfalen Weser Netz GmbH:企業の戦略的SWOT分析
    Westfalen Weser Netz GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • VAALCO Energy, Inc. (EGY)-石油・ガス分野:企業M&A・提携分析
    Summary VAALCO Energy, Inc. (VAALCO) is an upstream energy company. It acquires, explores, develops and produces crude oil and natural gas. The company conducts exploration activities as operator in Gabon and as a non-operator in Equatorial Guinea, West Africa. VAALCO also owns minor in certain non- …
  • LifeScan Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Qualcomm Incorporated (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Incorporated (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Genuine Parts Company:企業の戦略・SWOT・財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Denison Mines Corp (DNN):企業の財務・戦略的SWOT分析
    Denison Mines Corp (DNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • U.S. HealthWorks Medical Group:製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health, is a healthcare service provider that offers medicine and urgent care services. The center’s services include occupational medicine, urgent care, specialty care and therapy services. Its occupational medicine …
  • Intra-Cellular Therapies Inc (ITCI):企業の財務・戦略的SWOT分析
    Summary Intra-Cellular Therapies Inc (ICTI) is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurodegenerative diseases. Its pipeline products include lumateperone (ITI-007), used for the treatment of schizophrenia, behavioral disturbances associat …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Banco Santander (Brasil) SA:企業のM&A・事業提携・投資動向
    Banco Santander (Brasil) SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Santander (Brasil) SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • DexCom Inc (DXCM):医療機器:M&Aディール及び事業提携情報
    Summary DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring syst …
  • Arsenal Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Arsenal Medical Inc (Arsenal) is a medical technology company that develops polymer based foams and fibers. The company’s products comprise foam system for acute hemorrhage and DARPA collaboration products. Its foam system is an in-situ foaming foams, which is designed for the control of sev …
  • Provimi Holding BV:企業の戦略・SWOT・財務分析
    Provimi Holding BV - Strategy, SWOT and Corporate Finance Report Summary Provimi Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報
    Summary LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antib …
  • VytronUS Inc:医療機器:M&Aディール及び事業提携情報
    Summary VytronUS Inc (VytronUS), formerly CardionUS Inc, is an independent clinical stage medical device company that develops technologies for the treatment atrial fibrillation and other cardiac arrhythmias. The company is developing a catheter-based imaging and ablation platform based on low-inten …
  • Brasfield & Gorrie LLC:企業の戦略・SWOT・財務分析
    Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report Summary Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bank of Ayudhya Public Co Ltd (BAY):企業の財務・戦略的SWOT分析
    Bank of Ayudhya Public Co Ltd (BAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆